No Data
No Data
Sector Update: Health Care Stocks Advance in Afternoon Trading
Health care stocks were higher Thursday afternoon, with the NYSE Health Care Index rising 0.4% and the Health Care Select Sector SPDR Fund (XLV) up 0.6%.The iShares Biotechnology ETF (IBB) climbed 2.6
Top Midday Decliners
Salarius Pharmaceuticals (SLRX) said Thursday that the US Food and Drug Administration has placed a trial evaluating seclidemstat in combination with azacitidine in adult patients with
Sector Update: Health Care
Health care stocks were higher Thursday afternoon, with the NYSE Health Care Index rising 0.4% and the Health Care Select Sector SPDR Fund (XLV) up 0.6%.The iShares Biotechnology ETF (IBB) climbed 2.6
Express News | Salarius Pharmaceuticals Shares Down 21.6% Premarket as FDA Puts Cancer Drug Trial on Partial Clinical Hold
Express News | Salarius Pharmaceuticals Inc: Patient in Trial Experienced a Serious and Unexpected Grade 4 Adverse Event
Express News | Salarius Pharmaceuticals Notified By MD Anderson Cancer Center Of Grade 4 Adverse Event In Seclidemstat Clinical Trial; FDA Places Trial On Partial Clinical Hold; No New Patients Enrolled, Current Patients May Continue Treatment; Company To Support...
No Data
皓瓦 : GG
百富30y : runrunrun